Pharmaceuticals
12 total deals across 7 companies.
Latest Funding
Company
Location
Latest Round
Amount
Date
Leyden Labs
Leiden, Netherlands
—
Funding
$45.2M
Jun 25, 2026
Gilgamesh Pharma
United States
—
Series A
$60.0M
Mar 24, 2026
R1 Therapeutics
Toa Baja, United States
—
Series A
$77.5M
Mar 17, 2026
Slate Medicines
Raleigh, United States
—
Series A
$130.0M
Feb 24, 2026
Caldera Therapeutics
Cambridge, United States
—
Series A
$37.5M
Jan 14, 2026
Diagonal Therapeutics
Cambridge, United States
—
Series B
$125.0M
Jan 8, 2026
Parabilis Medicines
Cambridge, United States
—
Series F
$305.0M
Jan 8, 2026